CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 70 filers reported holding CTI BIOPHARMA CORP in Q1 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | 0.0% | 1 | -99.5% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 188 | -10.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 209 | -68.7% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 667 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 667 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 667 | -66.8% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 2,011 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 2,011 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -75.0% | 2,011 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | -66.7% | 2,011 | -17.8% | 0.00% | – |
Q2 2018 | $12,000 | +140.0% | 2,447 | +93.6% | 0.00% | – |
Q1 2018 | $5,000 | – | 1,264 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 4,684,404 | $21,876,000 | 9.07% |
Lion Point Capital, LP | 5,489,546 | $25,636,000 | 5.95% |
SILVERARC CAPITAL MANAGEMENT, LLC | 2,250,000 | $10,508,000 | 4.35% |
Bleichroeder LP | 3,859,707 | $18,025,000 | 3.20% |
NEA Management Company, LLC | 7,140,450 | $99,804,000 | 2.88% |
BVF INC/IL | 8,929,690 | $41,702,000 | 1.67% |
Ghost Tree Capital, LLC | 1,300,000 | $6,071,000 | 1.32% |
EAM Investors, LLC | 1,011,935 | $4,726,000 | 0.88% |
Knott David M Jr | 556,687 | $2,600,000 | 0.83% |
Sofinnova Investments, Inc. | 1,952,691 | $9,119,000 | 0.69% |